# US 11,077,317 B2 · Intravenous radiation treatment method > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 11,077,317 B2 - Document ID: US11077317B2 - Status: Granted - Kind: B2 - Application number: 16/182,585 - Filed: 2019-01-23 - Published: 2019-05-30 - Granted: 2021-08-03 - Earliest claimed: 2019-01-23 - Applicants: Warren Z McCarthy - Inventors: Warren Z McCarthy - Web page: https://patentgrep.com/patent/US11077317B2 ## CPC - A61N 5/0601: {Apparatus for use inside the body} - A61B 34/73: {Manipulators for magnetic surgery} - A61K 41/0057: {Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent} - A61K 49/1824: {coated or functionalised nanoparticles (liposomes A61K49/1812; nanoemulsions A61K49/1806; micelles A61K49/1809)} - A61N 5/062: {Photodynamic therapy, i.e. excitation of an agent} - A61B 2034/733: {arranged only on one side of the patient, e.g. under a table} - A61N 2005/0602: {for treatment of blood vessels} - A61N 2005/0628: {including a radiation sensor} - A61N 2005/0651: {Diodes} - A61N 2005/0659: {infrared} - A61N 2005/0661: {ultraviolet} - A61N 2005/0663: {Coloured light} - A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B) - A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D) - A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D) ## Abstract A method has been invented for intravenously inserting a tumor reduction radiation emitter into the body of a patient suffering from a cancerous tumor. The emitter is very small, yet detectable by medical imaging techniques and guidable by use of magnetism. The emitter is guided through the body by use of a magnet until it is adjacent or in in the tumor itself. The emitter can be oriented in various desired directions by the magnet. The emitter is then wirelessly powered by electrical induction, causing the radiation of a desired wavelength to be directed to tumor cells, causing tumor reduction. ## Claims ### Claim 1 A method for reducing a malignant tumor within the body of a human patient comprising the stops of: placing an electrical induction-powered intravenous tumor reduction radiation emitter within a venous passageway of the human patient, said intravenous tumor reduction radiation emitter including an elongate conductive body with a positive pole and a negative pole, a radiation emission module affixed to said elongate conductive body, said radiation emission module being in electrically conductive contact with said poles, said radiation emission module being capable of emitting radiation of a wavelength and intensity sufficient to cause necrosis of tumor tissue in order to achieve tumor reduction, using a magnet to guide said intravenous tumor reduction radiation emitter along said venous passageway to the location of a tumor in the body of said patient, using a magnet to orient said intravenous tumor reduction radiation emitter so that radiation which it emits is directed toward tissue of said tumor, locating said human patient and an electrical induction coil in proximity with each other, powering said induction coil to induce an electrical current in said elongate conductive body of said intravenous tumor reduction radiation emitter, allowing said electrical current to power said radiation emission module to cause it to emit radiation within said patient, and causing said emitted radiation to affect tumor tissue, thereby causing necrosis of said tumor tissue and reducing said tumor. ### Claim 2 (depends on 1) A method as recited in claim 1 further comprising the step of monitoring the location of said intravenous tumor reduction photonic emitter within said patient's body via medical imaging. ### Claim 3 (depends on 1) A method as recited in claim 1 further comprising the step of tuning the wavelength of radiation emitted by said radiation emission module to a wavelength that is absorbable by the tumor to be reduced. ### Claim 4 (depends on 1) A method as recited in claim 1 further comprising the step of tuning the wavelength of radiation emitted by said radiation emission module to a wavelength that is absorbable by a protein located on cells of the tumor to be reduced. ### Claim 5 (depends on 1) A method as recited in claim 1 further comprising the step of tuning the wavelength of radiation emitted by said radiation emission module to a wavelength that is absorbable by a protein located on cells of the tumor to be reduced. ### Claim 6 (depends on 1) A method as recited in claim 1 further comprising the step of introducing a radiation-absorbing material into blood supply of said tumor. ### Claim 7 (depends on 6) A method as recited in claim 6 further comprising the step of tuning the wavelength of radiation emitted by said radiation emission module to a wavelength that is absorbable by said radiation-absorbing material to enhance transmission of radiation energy to the tumor to be reduced. ### Claim 8 (depends on 7) A method as recited in claim 7 wherein said radiation-absorbing material is a dye. ### Claim 9 (depends on 7) A method as recited in claim 7 wherein said radiation-absorbing material is a metal nanoparticle. ### Claim 10 (depends on 7) A method as recited in claim 7 wherein said radiation-absorbing material is a polymer. ### Claim 11 (depends on 1) A method as recited in claim 1 wherein said radiation emission module is a semiconductor laser. ### Claim 12 (depends on 1) A method as recited in claim 1 wherein said radiation emission module is a light emitting diode. ### Claim 13 (depends on 1) A method as recited in claim 1 wherein said emitted radiation emission module emits a wavelength in the range of about 280 nm to 1080 nm. ### Claim 14 A method for reducing a malignant tumor within the body of a human patient comprising the stops of: depriving the patient of substantial carbohydrates for a period of time to cause the patient's blood sugar to drop, thereby causing the patient to go into a state of ketosis so that the patient's healthy cells burn ketones, introducing glucose and insulin to the blood supply for the tumor to be reduced, placing an electrical induction-powered intravenous tumor reduction radiation emitter within a venous passageway of the human patient, said intravenous tumor reduction radiation emitter including an elongate conductive body with a positive pole and a negative pole, a radiation emission module affixed to said elongate conductive body, said radiation emission module being in electrically conductive contact with said poles, said radiation emission module being capable of emitting radiation of a wavelength and intensity sufficient to cause necrosis of tumor tissue in order to achieve tumor reduction, using a magnet to guide said intravenous tumor reduction radiation emitter along said venous passageway to the location of a tumor in the body of said patient, using a magnet to orient said intravenous tumor reduction radiation emitter so that radiation which it emits is directed toward tissue of said tumor, locating said human patient and an electrical induction coil in proximity with each other, powering said induction coil to induce an electrical current in said elongate conductive body of said intravenous tumor reduction radiation emitter, allowing said electrical current to power said radiation emission module to cause it to emit radiation within said patient, and causing said emitted radiation to affect tumor tissue, thereby causing necrosis of said tumor tissue and reducing said tumor. ### Claim 15 (depends on 14) A method as recited in claim 14 further comprising the step of targeting the wavelength of said radiation to a wavelength absorbed by glucose. ### Claim 16 (depends on 14) A method as recited in claim 14 further comprising the steps of Identifying a protein located in tumor tissue which is not generally present in healthy tissue, targeting the wavelength of said radiation to a wavelength absorbed by said protein. ### Claim 17 (depends on 14) A method as recited in claim 14 further comprising the steps of introducing a tag-along molecule to said glucose, and targeting the wavelength of said radiation to a wavelength absorbed by said tag-along molecule.